Genertec Universal Medical Group Company Limited (5UM) — Strategic Asset Allocation Index

Latest as of June 2023: 25.6%

Genertec Universal Medical Group Company Limited (5UM) has a Strategic Asset Allocation Index of 25.6% as of June 2023. Strategic assets (PP&E of €5.04 Billion plus long-term investments of €-) total €5.04 Billion, measured against net assets of €19.69 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.

SAAI

25.6%
Strategic Assets / Net Assets

Strategic Assets

€5.04 Billion
PP&E + LT Investments

PP&E

€5.04 Billion
EUR

Net Assets

€19.69 Billion
EUR

Genertec Universal Medical Group Company Limited Strategic Asset Allocation Index (2016–2022)

This chart shows how Genertec Universal Medical Group Company Limited's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 25.6%, representing strategic assets of €5.04 Billion against net assets of €19.69 Billion EUR. Explore 5UM cash flow metrics to assess how effectively this company generates cash.

Annual Strategic Asset Allocation Index for Genertec Universal Medical Group Company Limited (2016–2022)

The table below presents the year-by-year Strategic Asset Allocation Index for Genertec Universal Medical Group Company Limited from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Genertec Universal Medical Group Company stock valuation.

Year SAAI Strategic Assets (EUR) PP&E LT Investments Net Assets Change (pp)
2022 25.0% €4.94 Billion €4.94 Billion €- €19.70 Billion ▲ +6.2 pp
2021 18.8% €3.32 Billion €3.32 Billion €- €17.62 Billion ▼ -2.0 pp
2020 20.8% €3.11 Billion €3.11 Billion €- €14.97 Billion ▼ -0.1 pp
2019 20.9% €2.81 Billion €2.81 Billion €- €13.45 Billion ▲ +18.3 pp
2018 2.6% €271.03 Million €271.03 Million €- €10.26 Billion ▲ +1.5 pp
2017 1.2% €86.88 Million €86.88 Million €- €7.47 Billion ▼ -0.3 pp
2016 1.5% €98.56 Million €98.56 Million €- €6.57 Billion
pp = percentage points